Nuvo Research Inc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: TheBusDriver who started this subject	12/13/2003 8:47:24 PM
From: axial	Read Replies (2) of 14101

This is the truth about Dimethaid, the facts: 1 - Management has made serious mistakes. 2 - Management's communication has been deplorable. 3 - The drugs are novel, highly competitive, and present problems to regulatory agencies. These problems mean delay and risk. 4 - Allegations about management misdeeds have been made: they are unproven 5 - Allegations are that "other" management could have made the approval of Pennsaid a quick process: that is unknowable, and unproven 6 - Dimethaid investors have been presented with a stream of anti-management invective that is unproven, and unverifiable. 7 - Some of the proponents of this stream of unverifiable (or demonstrably false) information are noted to have cooperated in attempts to become players in Oxo Chemie. This, by public admission. 8 - One of the proponents of this stream of unverifiable information, who publicly alleges management misconduct, has been involved twice in undisclosed attempts to gain a position, or to participate in an attempt to unseat management. These are the facts. Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next